Karlheinz Peter

Professor

20032019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2007

A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIbbeta3 (GPIIb/IIIa) antagonists

Bassler, N., Loeffler, C., Mangin, P., Yuan, Y-P., Schwarz, M., Hagemeyer, C. E., Eisenhardt, S. U., Ahrens, I., Bode, C., Jackson, S. & Peter, K., 2007, In : Arteriosclerosis, Thrombosis and Vascular Biology. 27, 3, p. 9 - 15 7 p.

Research output: Contribution to journalArticleResearchpeer-review

64 Citations (Scopus)

Antibodies as helpers: Targeted antithrombotic and fibrinolytic therapy

Schwarz, M., Hagemeyer, C. E., Peter, K. & Bode, C., 2007, In : Hamostaseologie. 27, 5, p. 360 - 362 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Single-chain antibodies as new antithrombotic drugs

Hagemeyer, C. E., Schwarz, M. & Peter, K., Mar 2007, In : Seminars in Thrombosis and Hemostasis. 33, 2, p. 185-195 11 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

13 Citations (Scopus)

Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation

Stoll, P., Bassler, N., Hagemeyer, C. E., Eisenhardt, S. U., Chen, Y-C., Schmidt, R., Schwarz, M., Ahrens, I., Katagiri, Y., Pannen, B., Bode, C. & Peter, K., 2007, In : Arteriosclerosis, Thrombosis and Vascular Biology. 27, 5, p. 1206 - 1212 7 p.

Research output: Contribution to journalArticleResearchpeer-review

66 Citations (Scopus)
2006

Conformation-specific blockade of the integrin GPIIb/IIIa: A novel antiplatelet strategy that selectively targets activated platelets

Schwarz, M., Meade, G., Stoll, P., Ylanne, J., Bassler, N., Chen, Y. C., Hagemeyer, C. E., Ahrens, I., Moran, N., Kenny, D., Fitzgerald, D. J., Bode, C. & Peter, K., 6 Jul 2006, In : Circulation Research. 99, 1, p. 25 - 33 9 p.

Research output: Contribution to journalArticleResearchpeer-review

119 Citations (Scopus)
2004

Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase

Hagemeyer, C. E., Tomic, I., Weirich, U., Graeber, J., Nordt, T. K., Runge, M. S., Bode, C. & Peter, K., 2004, In : Journal of Thrombosis and Haemostasis. 2, 5, p. 797 - 803 7 p.

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Fibrin-targeted direct factor Xa inhibition: Construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide

Hagemeyer, C. E., Tomic, I., Jaminet, P., Weirich, U., Bassler, N., Schwarz, M., Runge, M. S., Bode, C. & Peter, K., 2004, In : Thrombosis and Haemostasis. 92, 1, p. 47 - 53 7 p.

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)
2003

Improving selection of αIIbβ3-binding phage antibodies with increased reactivity derived from immunized donors

Jacobin, M. J., Robert, R., Pouns, O., Laroche-Traineau, J., Nurden, A., Peter, K., Little, M. & Clofent-Sanchez, G., 1 Sep 2003, In : Clinical Immunology. 108, 3, p. 199-210 12 p.

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)